Luke R Gagnon
Overview
Explore the profile of Luke R Gagnon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sadasivan C, Gagnon L, Ma C, Dion J, Kim D, Oudit G
JACC Case Rep
. 2025 Mar;
30(5):103191.
PMID: 40054907
Stroke-heart syndrome describes the neurocardiogenic mechanisms that lead to the development of poststroke cardiovascular complications. We describe a 25-year-old man with Carvajal syndrome who developed advanced biventricular heart failure 2 ...
2.
Sadasivan C, Gagnon L, Hazra D, Wang K, Youngson E, Thomas J, et al.
ESC Heart Fail
. 2024 Dec;
PMID: 39740200
Aims: Patients with cardiomyopathies are a heterogeneous group of patients who experience high morbidity and mortality. Early cardiac assessment and intervention with access to genetic counselling in a multidisciplinary Cardiomyopathy...
3.
Gagnon L, Hazra D, Perera K, Wang K, Kashyap N, Sadasivan C, et al.
Am Heart J
. 2024 Apr;
274:11-22.
PMID: 38670300
Background: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are effective in adults with diabetes mellitus (DM) and heart failure (HF) based on randomized clinical trials. We compared SGLT2 inhibitor uptake and outcomes in...
4.
Kashyap N, Nikhanj A, Gagnon L, Moukaskas B, Siddiqi Z, Oudit G
Eur Heart J Case Rep
. 2023 Feb;
7(1):ytad013.
PMID: 36727127
Background: Heart disease is an under-recognized cause of morbidity and mortality in patients with Emery-Dreifuss muscular dystrophy (EDMD). Arrhythmias and conduction delays are highly prevalent and given the rarity of...
5.
Gagnon L, Sadasivan C, Yogasundaram H, Oudit G
Curr Heart Fail Rep
. 2022 Sep;
19(6):458-466.
PMID: 36167917
Purpose Of Review: The coronavirus disease 2019 (COVID-19) pandemic has popularized the usage of hydroxychloroquine and chloroquine (HCQ/CQ) as treatments for COVID-19. Previously used as anti-malarial and now commonly used...
6.
Gagnon L, Huang Y, Kay R, Cujec B
CJC Open
. 2022 Apr;
4(3):337-339.
PMID: 35386129
We describe a case of Kounis syndrome, an allergic reaction causing coronary artery vasospasm, triggered by a vancomycin infusion, in a healthy 32-year-old man. The patient initially presented with an...
7.
Gagnon L, Sadasivan C, Perera K, Oudit G
Can J Cardiol
. 2021 Nov;
38(9):1331-1341.
PMID: 34737034
Cardiovascular complications from drugs of abuse are becoming more apparent because of increased usage worldwide. Substance abuse can cause acute and chronic cardiovascular complications and is increasing in prevalence especially...
8.
Sharif F, Gagnon L, Mulmi S, Roberts E
Water Res
. 2017 Mar;
114:237-245.
PMID: 28249215
In this work, two different reduced graphene oxide/iron oxide (rGO-IO) nanocomposites with different iron oxide loadings were fabricated using a one-step solvothermal method. The structure, properties and applications of the...